Alexander Robert Ingram

Affiliations

  • Director at Black Diamond Therapeutics Inc. (BDTX), 2021-03-23
  • Director at Biocryst Pharmaceuticals Inc (BCRX), 2021-03-02
  • Director at Novan Inc. (NOVN), 2020-07-31
  • Large Shareholder at Phasebio Pharmaceuticals Inc (PHAS), 2018-10-24
  • Director at Cree Inc (CREE), 2018-10-18
  • Large Shareholder at G1 Therapeutics Inc. (GTHX), 2018-06-01
  • Director at Valeant Pharmaceuticals International Inc. (VRX), 2017-04-04
  • Large Shareholder, Other at Clearside Biomedical Inc. (CLSD), 2017-01-20
  • Director at Regeneron Pharmaceuticals Inc (REGN), 2015-05-27
  • Director at Edwards Lifesciences Corp (EW), 2015-05-19
  • Director at Allergan Inc (AGN), 2012-10-31
  • Director at Pharmaceutical Product Development Inc (PPDI), 2011-12-06
  • Director at Lowes Companies Inc (LOW), 2011-04-04
  • Director at Valeant Pharmaceuticals International (VRX), 2010-10-01
  • Director at Osi Pharmaceuticals Inc (OSIP), 2010-06-09
  • Director at Wachovia Corp New (WB), 2009-01-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BDTX $30.46 5,000 Director 5,000 2020-09-30 Filing
BCRX $1.45 20,000 Director 48,088 2019-11-18 Filing
NOVN $2.21 50,000 Director 169,777 2019-05-22 Filing
NOVN $2.84 50,000 Director 119,777 2018-09-28 Filing
NOVN $4.70 8,465 Director 69,777 2017-08-29 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CREE $27.67 3,750 Director 48,846 2015-12-01 Filing
REGN $513.39 1,379 Director 1,500 2015-05-27 Filing
EW $90.26 12,500 Director 30,541 2014-07-31 Filing
EW $87.72 15,000 Director 36,856 2012-05-25 Filing
EW $87.79 10,000 Director 46,302 2011-05-09 Filing